Jeffrey W. Runge's Net Worth
$2.15 Million
Who is Jeffrey W. Runge?
Jeffrey W. Runge has an estimated net worth of $2.15 Million. This is based on reported shares across multiple companies, which include PHARMATHENE, INC, Aditxt, Inc., and Conmed Healthcare Management, Inc..
SEC CIK
Jeffrey W. Runge's CIK is 0001479091
Past Insider Trading and Trends
2016 was Jeffrey W. Runge's most active year for acquiring shares with 8 total transactions. Jeffrey W. Runge's most active month to acquire stocks was the month of May. 2016 was Jeffrey W. Runge's most active year for disposing of shares, totalling 7 transactions. Jeffrey W. Runge's most active month to dispose stocks was the month of August. 2017 saw Jeffrey W. Runge paying a total of $62,200.00 for 20,000 shares, this is the most they've acquired in one year. In 2012 Jeffrey W. Runge cashed out on 50,000 shares for a total of $66,700.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
PHARMATHENE, INC (ALT) Snapshot price: $10.45
InvestorJeffrey W. Runge owns 37,850 units of Common stock, $0.0001 par value per share which is worth $395,532.50 and 197,700 units of Common Stock, par value $0.0001 per share which is worth $2,065,965.00. From 2009 to 2017 Jeffrey W. Runge acquired a total of 197,850 shares in PHARMATHENE, INC at a cost of $365,071.84.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +11.25% | 20K |
$3.11 | $62,200.00 | 197.7K |
Jan 20
| |||
Form 4
| +12.68% | 20K |
$2.20 | $44,000.00 | 177.7K |
Nov 28
| |||
Form 4
| +318.30% | 120K |
$1.54 | $184,800.00 | 157.7K |
Sep 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
∞
| 20K |
$1.30 | $26,000.00 | 20K |
Dec 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
∞
| 17.85K |
$2.69 | $48,071.84 | 17.85K |
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aditxt, Inc. (ADTX) Snapshot price: $3.7829
InvestorJeffrey W. Runge owns 12,500 units of Common Stock which is worth $47,286.25. From 2020 to 2023 Jeffrey W. Runge acquired a total of 10,000 shares in Aditxt, Inc. at a cost of $29,343.70.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 29
| |||
Form 4
| +400.00% | 10K |
$2.93 | $29,343.70 | 12.5K |
Jun 1
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Oct 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 13
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Conmed Healthcare Management, Inc. No price found
InvestorJeffrey W. Runge used to own units in Common Stock but no longer holds any shares there. In the year 2011 Jeffrey W. Runge acquired a total of 10,000 shares in Conmed Healthcare Management, Inc., Jeffrey also disposed a total of 10,000 shares of Conmed Healthcare Management, Inc. equalling to $39,500.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -10.00K |
$3.95 | -$39,500.00 |
0
|
Aug 28 - Aug 29
| |||
Form 4
|
∞
| 10K |
—
|
—
| 10K |
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||